BIO-key shares resume trading on Nasdaq Capital Market after compliance notification

BIO-key International, Inc.

BIO-key International, Inc.

BKYI

0.00
  • BIO-key received Nasdaq notice that trading of its common stock will resume on the Nasdaq Capital Market at the July 8 open.
  • Trading restarts following a June 16 Nasdaq Hearings Panel decision that the company regained listing compliance, including bid-price and SEC filing rules.
  • Nasdaq will place the company under a discretionary panel monitor through July 6, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief on July 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.